Smith Asset Management Group »

Halozyme Therapeutics shares owned by Smith Asset Management Group

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Smith Asset Management Group from 13F filings

Historical chart of Smith Asset Management Group investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Smith Asset Management Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Smith Asset Management Group

Quarter filed Position value Share count Share price at filing
2012-03-31 $891M 70k 12760.00
2011-12-31 $681M 72k 9510.00
2011-09-30 $474M 77k 6140.00

More positions owned by Smith Asset Management Group

Apple Common Stock - Long (AAPL)
Microsoft Corp Common Stock - Long (MSFT)
Amazon.com Common Stock - Long (AMZN)
Facebook Common Stock - Long (META)
Alphabet Common Stock - Long (GOOGL)
Nvidia Corp Common Stock - Long (NVDA)
Fortinet Common Stock - Long (FTNT)
Adobe Common Stock - Long (ADBE)
United Parcel Service Common Stock - Long (UPS)
Jpmorgan Chase & Co Common Stock - Long (JPM)
Parker-Hannifin Corp Common Stock - Long (PH)
Target Corp Common Stock - Long (TGT)
Capital One Financial Corp Common Stock - Long (COF)
Paypal Holdings Common Stock - Long (PYPL)
Epam Systems Common Stock - Long (EPAM)

View all positions for Smith Asset Management Group

Top funds holding Halozyme Therapeutics

BlackRock
Vanguard Group
Artisan Partners Limited Partnership
Alliancebernstein
Jpmorgan Chase & Co
TD Asset Management
Jennifer Ranahan
Dimensional Fund Advisors
Charles Schwab Investment Management
Arrowpoint Asset Management
Goldman Sachs Group
T. Rowe Price Associates
Norges Bank Investment Management
Bank of New York Mellon
Bank of America Corporation

View all funds holding Halozyme Therapeutics